AGAPE ATP CORPORATION Proceeds from Sale of Investment Projects
AGAPE ATP CORPORATION (ATPC) reported Proceeds from Sale of Investment Projects of $121 for the 12-month period ending 2020-12-31, per its 10-K/A filed 2022-07-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfInvestmentProjects · last filed 2022-07-05
- AGAPE ATP CORPORATION proceeds from sale of investment projects for fiscal 2020 was $121.00.
| Period end | Proceeds from Sale of Investment Projects 12 month |
|---|---|
| 2020-12-31 | $121.00 10-K/A · filed 2022-07-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |